BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 26908603)

  • 41. The molecular landscape of glioma in patients with Neurofibromatosis 1.
    D'Angelo F; Ceccarelli M; Tala ; Garofano L; Zhang J; Frattini V; Caruso FP; Lewis G; Alfaro KD; Bauchet L; Berzero G; Cachia D; Cangiano M; Capelle L; de Groot J; DiMeco F; Ducray F; Farah W; Finocchiaro G; Goutagny S; Kamiya-Matsuoka C; Lavarino C; Loiseau H; Lorgis V; Marras CE; McCutcheon I; Nam DH; Ronchi S; Saletti V; Seizeur R; Slopis J; Suñol M; Vandenbos F; Varlet P; Vidaud D; Watts C; Tabar V; Reuss DE; Kim SK; Meyronet D; Mokhtari K; Salvador H; Bhat KP; Eoli M; Sanson M; Lasorella A; Iavarone A
    Nat Med; 2019 Jan; 25(1):176-187. PubMed ID: 30531922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Temporal, spatial, and genetic constraints contribute to the patterning and penetrance of murine neurofibromatosis-1 optic glioma.
    Brossier NM; Thondapu S; Cobb OM; Dahiya S; Gutmann DH
    Neuro Oncol; 2021 Apr; 23(4):625-637. PubMed ID: 33080011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors.
    Jecrois ES; Zheng W; Bornhorst M; Li Y; Treisman DM; Muguyo D; Huynh S; Andrew SF; Wang Y; Jiang J; Pierce BR; Mao H; Krause MK; Friend A; Nadal-Nicolas F; Stasheff SF; Li W; Zong H; Packer RJ; Zhu Y
    Dev Cell; 2021 Oct; 56(20):2871-2885.e6. PubMed ID: 34428430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurological malignancies in neurofibromatosis type 1.
    Eoli M; Saletti V; Finocchiaro G
    Curr Opin Oncol; 2019 Nov; 31(6):554-561. PubMed ID: 31436563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurofibromin expression and astrogliosis in neurofibromatosis (type 1) brains.
    Nordlund ML; Rizvi TA; Brannan CI; Ratner N
    J Neuropathol Exp Neurol; 1995 Jul; 54(4):588-600. PubMed ID: 7602332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosity.
    Brown JA; Gianino SM; Gutmann DH
    J Neurosci; 2010 Apr; 30(16):5579-89. PubMed ID: 20410111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations.
    Sharif S; Upadhyaya M; Ferner R; Majounie E; Shenton A; Baser M; Thakker N; Evans DG
    J Med Genet; 2011 Apr; 48(4):256-60. PubMed ID: 21278392
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.
    Anastasaki C; Mo J; Chen JK; Chatterjee J; Pan Y; Scheaffer SM; Cobb O; Monje M; Le LQ; Gutmann DH
    Nat Commun; 2022 May; 13(1):2785. PubMed ID: 35589737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice.
    Brown JA; Emnett RJ; White CR; Yuede CM; Conyers SB; O'Malley KL; Wozniak DF; Gutmann DH
    Hum Mol Genet; 2010 Nov; 19(22):4515-28. PubMed ID: 20826448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.
    Anderson DM; Van de Plas R; Rose KL; Hill S; Schey KL; Solga AC; Gutmann DH; Caprioli RM
    J Proteomics; 2016 Oct; 149():77-84. PubMed ID: 26883872
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies.
    Chen Y; Yu J; Ge S; Jia R; Song X; Wang Y; Fan X
    Invest Ophthalmol Vis Sci; 2024 Jun; 65(6):8. PubMed ID: 38837168
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation.
    Gutmann DH; Loehr A; Zhang Y; Kim J; Henkemeyer M; Cashen A
    Oncogene; 1999 Aug; 18(31):4450-9. PubMed ID: 10442636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes.
    Dasgupta B; Dugan LL; Gutmann DH
    J Neurosci; 2003 Oct; 23(26):8949-54. PubMed ID: 14523097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurofibromatosis type 1 in two siblings due to maternal germline mosaicism.
    Trevisson E; Forzan M; Salviati L; Clementi M
    Clin Genet; 2014 Apr; 85(4):386-9. PubMed ID: 23621909
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RNA sequence analysis reveals ITGAL/CD11A as a stromal regulator of murine low-grade glioma growth.
    De Andrade Costa A; Chatterjee J; Cobb O; Sanapala S; Scheaffer S; Guo X; Dahiya S; Gutmann DH
    Neuro Oncol; 2022 Jan; 24(1):14-26. PubMed ID: 34043012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.
    Kuhrt LD; Motta E; Elmadany N; Weidling H; Fritsche-Guenther R; Efe IE; Cobb O; Chatterjee J; Boggs LG; Schnauß M; Diecke S; Semtner M; Anastasaki C; Gutmann DH; Kettenmann H
    Dis Model Mech; 2023 Dec; 16(12):. PubMed ID: 37990867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improving outcomes for neurofibromatosis 1-associated brain tumors.
    Brossier NM; Gutmann DH
    Expert Rev Anticancer Ther; 2015 Apr; 15(4):415-23. PubMed ID: 25652347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Midkine activation of CD8
    Guo X; Pan Y; Xiong M; Sanapala S; Anastasaki C; Cobb O; Dahiya S; Gutmann DH
    Nat Commun; 2020 May; 11(1):2177. PubMed ID: 32358581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development.
    Shin J; Padmanabhan A; de Groh ED; Lee JS; Haidar S; Dahlberg S; Guo F; He S; Wolman MA; Granato M; Lawson ND; Wolfe SA; Kim SH; Solnica-Krezel L; Kanki JP; Ligon KL; Epstein JA; Look AT
    Dis Model Mech; 2012 Nov; 5(6):881-94. PubMed ID: 22773753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection and measurement of neurofibromatosis-1 mouse optic glioma in vivo.
    Banerjee D; Hegedus B; Gutmann DH; Garbow JR
    Neuroimage; 2007 May; 35(4):1434-7. PubMed ID: 17383899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.